Transcription factor NF-κB participates in regulation of epithelial cell turnover in the colon

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 279, Issue 6 42-6, 2000, Pages

  Inan, Mehmet Sait ^a   Tolmacheva, Veronica ^a   Wang, Qiang Shu ^a   Rosenberg, Daniel W ^a   Giardina, Charles ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Cell proliferation; Nerve growth factor ; Nuclear factor B; Tumor necrosis factor

Indexed keywords

BROXURIDINE; CYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE GROWTH FACTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LABELING; CELL PROLIFERATION; COLON MUCOSA; DNA BINDING; EPITHELIUM CELL; GENE EXPRESSION; GENE REPRESSION; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TURNOVER TIME;

EID: 0033637178     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2000.279.6.g1282     Document Type: Article

References (69)

1. Overexpression of tumor necrosis factor alpha in the brain of transgenic mice differentially alters nerve growth factor levels and choline acetyltransferase activity
2. Immunosuppression by glucecorticoids: Inhibition of NF-κB activity through induction of IκB synthesis
3. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-κappaB p50
4. Tumor necrosis factor alpha antibody (inflixmab) therapy profoundly downregulates the inflammation in Crohn's ileocolitis
5. Function and activation of NF-κB in the immune system
6. Apoptosis: Activate NF-κB or die?
7. 1 transition in mouse fibroblasts
8. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells
9. Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon
10. An essential role for NF-κB in preventing TNF-α-induced cell death
11. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: Mechanism for NF-κB activation
12. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
13. Inhibition of NF-κB activity induces apoptosis in murine hepatocytes
14. Mutations in the IκBα gene in Hodgkin's disease suggest a tumor suppressor role for IκBα
15. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-κB p50-p65 recruitment
16. Relationship between extracellular matrix interactions and degree of differentiation in human colon carcinoma cell lines
17. Intestinal NF-κB is activated, mainly as p50 homodimers, by platelet-activating factor
18. Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells
19. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB
20. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop
21. Tyrosine kinase and MAPK inhibition of TNF-alpha and EGF-stimulated IEC-6 cell growth
22. Structure and biosynthesis of nerve growth factor
23. The effect of sodium salicylate and aspirin on NF-κB
24. Disruption of epithelial cell-matrix interactions induces apoptosis
25. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
26. NF-κB and REL proteins: Evolutionarily conserved mediators of immune responses
27. The IκB protein: Members of a multifunctional family
28. Constitutive activation of NF-κB causes resistance to apoptosis in cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates
29. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
30. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
31. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression
32. 1-to-S-phase transition
33. Separation of pure populations of epithelial cells from rabbit distal colon
34. NF-κB prevents apoptosis and liver dysfunction during liver regeneration
35. Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line
36. Conversion of TNF-alpha from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase
37. Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappa B activation in mouse colonocytes
38. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6
39. NF-κB subunit-specific regulation of the interleukin-8 promoter
40. Selection of optimal κB/Rel DNA binding motifs: Interaction of both subunits of NF-κB with DNA is required for transcriptional activation
41. Differential regulation of the c-myc oncogene promoter by the NF-κB/rel family of transcription factors
42. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway
43. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B
44. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation
45. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions
46. Role of IL-1 beta and TNF-alpha in the regulation of NGF in experimentally induced arthritis in mice
47. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
48. Secretion imbalance between tumor necrosis factor and its inhibitor in inflammatory bowel disease
49. The stress-response proteins poly(ADP-ribose) polymerase and NF-kappaB protect against bile salt-induced apoptosis
50. Ultrastructure of cell loss in intestinal mucosa
51. A requirement for NF-κB activation in Bcr-Ablmediated transformation
52. Nuclear factor κB is activated in macrophages and epithelial cells of inflamed mucosa
53. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination
54. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB
55. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune cell responses
56. Inhibition of nuclear factor kappa B (NF-κB) activity induces nerve growth factor-resistant apoptosis in PC12 cells
57. NF-κB: A lesson in family values
58. Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract
59. IκB-β regulates the persistent response in biphasic activation of NF-κB
60. Suppression of TNF-α-induced apoptosis by NF-κB
61. Nerve growth factor synthesis by intestinal epithelial cells
62. The v-rel oncogene: Insights into the mechanism of transcriptional activation, repression, and transformation
63. TNF- and cancer therapy-induced apoptosis Potentiation by inhibition of NF-κB
64. Altered expression of cyclin D1 and cyclin-dependent kinase 4 in AOM-induced mouse colon tumorigenesis
65. Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha
66. High-level expression of IκBβ in the surface epithelium of the colon: In vitro evidence for an immunomodulatory role
67. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
68. Lipopolysaccharide induction of the TNF-α promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-κB transcription factors
69. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation